Market Cap | 15.93M | P/E | - | EPS this Y | 55.50% | Ern Qtrly Grth | - |
Income | -12.42M | Forward P/E | -1.36 | EPS next Y | 57.10% | 50D Avg Chg | -11.00% |
Sales | 18.16M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -19.00% |
Dividend | N/A | Price/Book | 0.91 | EPS next 5Y | - | 52W High Chg | -53.00% |
Recommedations | 2.00 | Quick Ratio | 1.61 | Shares Outstanding | 21.54M | 52W Low Chg | 15.00% |
Insider Own | 8.06% | ROA | -24.54% | Shares Float | 16.34M | Beta | 1.46 |
Inst Own | 14.63% | ROE | -83.20% | Shares Shorted/Prior | 193.55K/73.06K | Price | 1.18 |
Gross Margin | 51.83% | Profit Margin | -68.41% | Avg. Volume | 34,688 | Target Price | 6.25 |
Oper. Margin | -47.17% | Earnings Date | Oct 24 | Volume | 81,525 | Change | 6.31% |
Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.
HC Wainwright & Co. | Buy | Jul 30, 24 |
Lake Street | Buy | Jun 24, 24 |
HC Wainwright & Co. | Buy | Apr 30, 24 |
HC Wainwright & Co. | Buy | Mar 5, 24 |
HC Wainwright & Co. | Buy | Jan 22, 24 |
HC Wainwright & Co. | Buy | Apr 28, 23 |
HC Wainwright & Co. | Buy | Mar 30, 23 |
HC Wainwright & Co. | Buy | Jul 29, 22 |
HC Wainwright & Co. | Buy | Oct 30, 20 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Davis Scott G. | President & COO President & COO | Aug 17 | Sell | 0.9956 | 37,446 | 37,281 | 331,372 | 08/18/23 |
Wong Jerome | Chief Financial Offi.. Chief Financial Officer | Aug 17 | Sell | 0.9956 | 12,784 | 12,728 | 266,953 | 08/18/23 |
SHERMAN STEVEN | Executive Chair Executive Chair | May 24 | Sell | 1.4427 | 45,660 | 65,874 | 364,913 | 05/26/23 |
Jones Jason C | Chief Operating Offi.. Chief Operating Officer | May 08 | Sell | 1.5723 | 3,435 | 5,401 | 138,554 | 05/17/23 |
SHERMAN STEVEN | Executive Chair Executive Chair | Dec 04 | Option | 0 | 31,198 | 739,240 | 12/07/22 | |
SHERMAN STEVEN | Executive Chair Executive Chair | Dec 04 | Sell | 1.28 | 10,576 | 13,537 | 728,664 | 12/07/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Nov 21 | Option | 0 | 15,599 | 713,829 | 11/23/22 | |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Nov 21 | Sell | 1.26 | 5,787 | 7,292 | 708,042 | 11/23/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Sep 21 | Option | 0 | 15,599 | 694,594 | 09/26/22 | |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Sep 21 | Sell | 1.75 | 6,043 | 10,575 | 688,551 | 09/26/22 |
Jones Jason C | Senior VP Product De.. Senior VP Product Development | Aug 31 | Sell | 2.3134 | 5,873 | 13,587 | 125,764 | 09/02/22 |
Wong Jerome | InterimChief Financi.. InterimChief Financial Officer | Aug 03 | Sell | 1.8038 | 1,675 | 3,021 | 102,192 | 08/04/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Jul 21 | Option | 0 | 15,599 | 674,630 | 07/25/22 | |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Jul 21 | Sell | 1.75 | 5,662 | 9,908 | 668,968 | 07/25/22 |
Wong Jerome | InterimChief Financi.. InterimChief Financial Officer | Jul 18 | Sell | 1.7054 | 98 | 167 | 103,867 | 07/20/22 |
Davis Scott G. | President & COO President & COO | Jun 30 | Sell | 1.72 | 4,997 | 8,595 | 368,818 | 07/05/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Jun 21 | Option | 0 | 15,599 | 664,361 | 06/22/22 | |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Jun 21 | Sell | 1.74 | 5,330 | 9,274 | 659,031 | 06/22/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Jun 10 | Sell | 1.9 | 6,911 | 13,131 | 648,762 | 06/17/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | May 24 | Sell | 1.7591 | 6,597 | 11,605 | 637,408 | 05/26/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Apr 28 | Sell | 2.4076 | 6,862 | 16,521 | 628,406 | 05/02/22 |
Davis Scott G. | President & COO President & COO | Apr 20 | Sell | 2.6176 | 4,043 | 10,583 | 73,815 | 04/26/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Apr 21 | Option | 0.00 | 15,599 | 635,268 | 04/25/22 | |
GLENN JOHN | Chief Financial Offi.. Chief Financial Officer | Mar 22 | Sell | 2.8197 | 3,462 | 9,762 | 35,130 | 03/28/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Mar 24 | Sell | 2.94 | 6,389 | 18,784 | 619,669 | 03/25/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Mar 21 | Option | 0.00 | 15,599 | 626,058 | 03/22/22 | |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Mar 15 | Sell | 2.5999 | 5,965 | 15,508 | 610,459 | 03/17/22 |
SHERMAN STEVEN | CEO & Chairman CEO & Chairman | Mar 08 | Option | 0.00 | 15,599 | 616,424 | 03/10/22 |